184 related articles for article (PubMed ID: 26449764)
1. Renal extramedullary hematopoiesis: interstitial and glomerular pathology.
Alexander MP; Nasr SH; Kurtin PJ; Casey ET; Hernandez LP; Fidler ME; Sethi S; Cornell LD
Mod Pathol; 2015 Dec; 28(12):1574-83. PubMed ID: 26449764
[TBL] [Abstract][Full Text] [Related]
2. Membranous Nephropathy and Intrarenal Extramedullary Hematopoiesis in a Patient With Myelofibrosis.
Philipponnet C; Ronco P; Aniort J; Kemeny JL; Heng AE
Am J Kidney Dis; 2017 Dec; 70(6):874-877. PubMed ID: 28821362
[TBL] [Abstract][Full Text] [Related]
3. Primary Myelofibrosis-Related Renal Disorders Treated with a Janus Kinase Inhibitor.
Asou M; Asakawa T; Araki M; Ehara T; Hishima T; Sakamaki H
Case Rep Nephrol Dial; 2021; 11(1):1-9. PubMed ID: 33614736
[TBL] [Abstract][Full Text] [Related]
4. Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.
Person F; Meyer SC; Hopfer H; Menter T
Virchows Arch; 2021 Nov; 479(5):1013-1020. PubMed ID: 34164707
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Pathological Features of Renal Presentations in Polycythemia Vera.
Yang J; Yu X; Hu N; Su T
Am J Med Sci; 2022 Jan; 363(1):33-41. PubMed ID: 34687616
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic myelofibrosis associated with renal extramedullary hematopoiesis and nephrotic syndrome: case report.
Liu TT; Chen JB; Chen WJ; Kuo CY; Lee CT
Chang Gung Med J; 2000 Mar; 23(3):169-74. PubMed ID: 15641221
[TBL] [Abstract][Full Text] [Related]
7. Myeloproliferative neoplasms cause glomerulopathy.
Said SM; Leung N; Sethi S; Cornell LD; Fidler ME; Grande JP; Herrmann S; Tefferi A; D'Agati VD; Nasr SH
Kidney Int; 2011 Oct; 80(7):753-9. PubMed ID: 21654720
[TBL] [Abstract][Full Text] [Related]
8. Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL-Negative Myeloproliferative Neoplasms.
Belliere J; Colombat M; Kounde C; Recher C; Ribes D; Huart A; Chauveau D; Demas V; Luquet I; Beyne-Rauzy O; Tavitian S; Faguer S
Kidney Int Rep; 2021 Mar; 6(3):737-745. PubMed ID: 33732988
[TBL] [Abstract][Full Text] [Related]
9. Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era.
Del Sordo R; Brugnano R; Covarelli C; Fiorucci G; Falzetti F; Barbatelli G; Nunzi E; Sidoni A
Clin Nephrol Case Stud; 2017; 5():70-77. PubMed ID: 29350220
[TBL] [Abstract][Full Text] [Related]
10. Novel Detection of CALR-Mutated Cells in Myeloproliferative Neoplasm-Related Glomerulopathy With Interstitial Extramedullary Hematopoiesis: A Case Report.
Maruyama K; Nakagawa N; Suzuki A; Kabara M; Matsuki M; Shindo M; Iwasaki S; Ogawa Y; Hasebe N
Am J Kidney Dis; 2019 Dec; 74(6):844-848. PubMed ID: 31377025
[TBL] [Abstract][Full Text] [Related]
11. Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms.
Büttner-Herold M; Sticht C; Wiech T; Porubsky S
Histopathology; 2021 Apr; 78(5):738-748. PubMed ID: 33078472
[TBL] [Abstract][Full Text] [Related]
12. Acquired glomerular lesions in patients with Down syndrome.
Said SM; Cornell LD; Sethi S; Fidler ME; Al Masri O; Marple J; Nasr SH
Hum Pathol; 2012 Jan; 43(1):81-8. PubMed ID: 21733549
[TBL] [Abstract][Full Text] [Related]
13. Novel findings of splenic extramedullary hematopoiesis during primary myelofibrosis, post-essential thrombocythemia, and post-polycythemia vera myelofibrosis.
Guy A; Bidet A; Ling C; Caumont C; Boureau L; Viallard JF; Parrens M
Virchows Arch; 2021 Oct; 479(4):755-764. PubMed ID: 33934231
[TBL] [Abstract][Full Text] [Related]
14. Hematological Malignancies and the Kidney.
Abramson M; Mehdi A
Adv Chronic Kidney Dis; 2022 Mar; 29(2):127-140.e1. PubMed ID: 35817520
[TBL] [Abstract][Full Text] [Related]
15. Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy.
Markowitz GS; Radhakrishnan J; Kambham N; Valeri AM; Hines WH; D'Agati VD
J Am Soc Nephrol; 2000 Aug; 11(8):1439-1448. PubMed ID: 10906157
[TBL] [Abstract][Full Text] [Related]
16. Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis.
Konoplev S; Hsieh PP; Chang CC; Medeiros LJ; Lin P
Hum Pathol; 2007 Dec; 38(12):1760-3. PubMed ID: 17707884
[TBL] [Abstract][Full Text] [Related]
17. Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib.
Rajasekaran A; Ngo TT; Abdelrahim M; Glass W; Podoll A; Verstovsek S; Abudayyeh A
BMC Nephrol; 2015 Aug; 16():121. PubMed ID: 26232031
[TBL] [Abstract][Full Text] [Related]
18. Mass-like extramedullary hematopoiesis: imaging features.
Ginzel AW; Kransdorf MJ; Peterson JJ; Garner HW; Murphey MD
Skeletal Radiol; 2012 Aug; 41(8):911-6. PubMed ID: 22101909
[TBL] [Abstract][Full Text] [Related]
19. Characterization of proteinuria in primary glomerulonephritides. SDS-PAGE patterns: clinical significance and prognostic value of low molecular weight ("tubular") proteins.
Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
Am J Kidney Dis; 1997 Jan; 29(1):27-35. PubMed ID: 9002527
[TBL] [Abstract][Full Text] [Related]
20. Atypical presentation of acute post-infectious glomerulonephritis in patients with sickle cell disease: report of two cases.
de Menezes Neves PDM; Reichert BV; Bridi RA; Yu L; Dias CB; Pinheiro RBB; de Abreu Testagrossa L; Cavalcante LB; Malheiros DMAC; Jorge LB; Woronik V
BMC Nephrol; 2020 Feb; 21(1):56. PubMed ID: 32093686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
